Irfan Zeb

Irfan Zeb practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Irfan Zeb's NPI, 1154681229, was assigned on May 23, 2012. Irfan Zeb holds West Virginia license 28128.

Irfan Zeb's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Irfan Zeb's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Irfan Zeb is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Irfan Zeb to 4 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Irfan Zeb practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Irfan Zeb's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Irfan Zeb is licensed in West Virginia.

CMS data shows 841 Medicare services from Irfan Zeb across 19 procedure codes in 2024, for 553 Medicare patients. Medicare paid $48,632 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 553 Medicare patients who saw Irfan Zeb in 2024. The largest group is 65 to 74, with 255 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Irfan Zeb's median patient age at 69, with 45% women.

In 2024, Irfan Zeb wrote 304 Medicare Part D claims for 94 patients. 87% of them were for generic drugs. CMS names the drug for 212 of them, across 10 drugs with 11 or more claims each, at $23,246 in total drug cost. In 2023, CMS named 115 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Irfan Zeb for performance year 2024, reported through an alternative payment model (APM). Irfan Zeb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 56 papers to Irfan Zeb, published from 2010 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Coronary Artery Disease, Tomography, X-Ray Computed and Predictive Value of Tests. Irfan Zeb has published most often in J Cardiovasc Comput Tomogr. Irfan Zeb's most frequent co-authors are Matthew J. Budoff, MD, Khurram Nasir, MD, MPH and Roger Scott Blumenthal, MD.

Dmand AI links Irfan Zeb to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ischemia and Coronary Artery Disease.

CMS Open Payments shows 13 general payments to Irfan Zeb from 6 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 62% of the total. HeartFlow, Inc. paid the most, $854.